We report the case of a pancreatic ductal adenocarcinoma (PDAC) in the remnant pancreas of a 78-year-old man after pancreaticoduodenectomy for acinar cell carcinoma.
Introduction
Acinar cell carcinoma (ACC) is a relatively rare pancreatic neoplasm. Although the pancreas predominantly consists of acinar cells (82% total pancreatic volume), ACC accounts for approximately 1% of all pancreatic neoplasms 1, 2 . The reason for the low prevalence of ACC remains unclear, although some researchers have speculated that acinar cells may undergo metaplasia into ductal cells when they encounter genetic instability. The prognosis of ACC remains controversial because some patients show poor prognosis, while others show a better prognosis compared with patients with pancreatic ductal adenocarcinoma (PDAC) [3] [4] [5] . Patients who present with localized disease show a better prognosis than those with metastases. However, even after curative resection, there is still a high rate of recurrence 3, 6 . Some authors have reported that most patients develop either local or liver recurrence 7 . Currently, there is no report in the literature regarding other types of carcinoma recurring in the remnant pancreas.
Here, we discuss the case of a PDAC in the remnant pancreas of a patient after pancreaticoduodenectomy for ACC.
Case report
A 78-year-old man presented with hematuria at our clinic. He had no risk factors, including a family history of pancreatic cancer, medical history of diabetes, obesity, or alcohol abuse. Enhanced abdominal computed tomography (CT) was performed to examine the cause of hematuria, and it revealed an approximately 2 cm in diameter mass lesion in the head of the pancreas (Fig. 1 ). Blood test results showed normal values, as well as normal levels of tumor markers carcinoembryonic antigen and cancer antigen 19-9 (CA19-9). Endoscopic ultrasound (EUS) showed a low-echoic mass in the head of the pancreas (Fig. 2) . Poorly differentiated carcinoma was suspected based on EUS fine-needle aspiration biopsy. For the diagnosis of pancreatic carcinoma, subtotal stomach-preserving pancreaticoduodenectomy was performed. Macroscopically, the tumor appeared well circumscribed, and the cut surface showed a solid tumor (Fig. 3) .
Microscopically, the tumor cells were arranged in combination patterns, with solid or trabecular anastomosing structures and glandular cells (Fig. 4a) .
Immunohistochemically, the tumor cells were immunoreactive for trypsin and amylase but were negative for chromogranin, synaptophysin, and CD56 staining (Fig. 4b) . The non-cancerous region of the pancreas showed chronic pancreatitis, and the dissected peripancreatic tissue margin was negative for carcinoma. The pathological diagnosis was ACC of the pancreas, stage IA pT1, pN0, M0 (Union for International Cancer
Control staging, 8th edition), without regional lymph node invasion.
The postoperative course was uneventful, with the patient being discharged on the 12th postoperative day. After the operation, no adjuvant therapy was administered because the patient refused the treatment. Twenty-two months after surgery, CA19-9 levels gradually increased to 163 U/mL. Therefore, a recurrence of pancreatic cancer was Lipase hypersecretion syndrome is recognized to be secondary to lipase hypersecretion by ACC 3, 8 . ACC may have different histological features, ranging from acinar structures similar to normal pancreatic acini to solid growths composed of large sheets of poorly differentiated neoplastic cells 9 . A pathological diagnosis of ACC is rarely achieved preoperatively, and surgeons should thus be cognizant of ACC when dealing with pancreatic cases. In this report, the patient had no specific features. We could not preoperatively diagnose the tumor as ACC, though EUS-guided fine-needle biopsy and immunohistochemistry are typically utilized when ACC is diagnosed preoperatively 10 .
Although the prognosis of ACC might be better than that of PDAC, it remains poor due to metastatic disease and a high rate of recurrence, as described above. In this case, surgical resection with negative margins was performed for ACC in the head of the pancreas. Twenty-five months after surgery, PDAC developed in the remnant pancreas of our patient. There were different histopathological findings between the first tumor and two recurrent masses. Though the tumor was resectable, chemoradiotherapy was performed due to the patient's refusal to undergo surgery.
There are few reports in the literature on pancreatic carcinoma recurrence in the remnant pancreas after pancreaticoduodenectomy. Ishida reported that the incidence rate of secondary PDAC in the remnant pancreas after pancreatectomy for PDAC is markedly high. The cumulative 3-and 5-year incidence rates were 3.1% and 17.7%, respectively 13 . With respect to ACC, there was no report about PDAC development in the remnant pancreas after a pancreaticoduodenectomy.
ACC has histological variants such as mixed acinar-neuroendocrine carcinoma and mixed acinar-ductal adenocarcinoma 9 . In this case, the first ACC tumor did not contain ductal differentiation or a significant neuroendocrine component. However, biopsy of the second tumor in the remnant pancreas showed adenocarcinoma.
Diagnosis based on pathology is limited. We could not accurately diagnose the tumor in the remnant pancreas because the specimens were partially obtained by fine-needle biopsy and not surgery or autopsy. Mixed pathological-type tumor exists in the case of pancreatic cancer and even in secondary tumors. In spite of pathological diagnosis, there still remains possibility that the remnant pancreatic cancer is a development of mixed-type ACC.
The molecular mechanisms involved in ACC are not completely understood. In general, the typical abnormalities of PDAC, including mutations in KRAS, DPC4, p16, and TP53, are absent or very rare in ACC 9, 14 . ACC has different gene alterations from those of PDAC. In our case, PDAC developed in the remnant pancreas after surgery for ACC. Therefore, there might be some relation of genetic alterations between ACC and PDAC, though genetic profiling was not performed for the tumors in our case.
We reported the first case of PDAC in the remnant pancreas after pancreaticoduodenectomy for ACC. Because this is an extremely rare case, further cases and studies are needed to understand its pathogenesis. 
